Sai Parenteral's Limited IPO
Mainboard
₹ NaN /N/A Shares
24 Mar, 2026
Open Date27 Mar, 2026
Close Date30 Mar, 2026
Allotment Date02 Apr, 2026
Listing DateSai Parenteral's IPO Issue Details
- Issue Price ₹N/A per equity share
- Face Value ₹5 Per Equity Share
- Issue Price ₹285 Cr (Fresh Issue) + 31.57 Lakh Shares (OFS)
- Listing at BSE, NSE
- Lead Manager Arihant Capital Markets Ltd.
- Registrar Bigshare Services Pvt.Ltd.
Sai Parenteral's IPO Details
- Retail Portion 35%
Sai Parenteral's IPO Details
The IPO of Sai Parenteral's is priced at ₹N/A per equity share, which has a face value of ₹5 Per Equity Share each, IPO bidding starts from Mar 24, 2026 and ends on Mar 27, 2026. The allotment for Sai Parenteral's IPO will be finalized on Mar 30, 2026. Sai Parenteral's IPO will be listed on BSE, NSE, with a tentative listing date fixed as Apr 2, 2026. The company shall list its equity shares on the BSE, NSE. Bigshare Services Pvt.Ltd. is the registrar of the issue.
The book-running lead manager for the IPO is/are Arihant Capital Markets Ltd..
The Sai Parenteral's IPO sets its price band at N/A for each share. A single application for Sai Parenteral's Limited IPO must contain at least N/A shares.
Read More
Sai Parenteral's Valuations
Sai Parenteral's Company Financials
| 30-Sep-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 376.24 | 272.39 | 268.10 | 133.96 |
| Revenue | 89.43 | 163.74 | 155.18 | 97.03 |
| Profit After Tax | 7.76 | 14.43 | 8.42 | 4.38 |
| Net Worth | 209.37 | 95.78 | 76.40 | 31.49 |
| Reserves & Surplus | 188.84 | 80.36 | 61.30 | 24.34 |
| Total Borrowing | 76.07 | 93.95 | 118.79 | 68.55 |
About Sai Parenteral's Company
Established in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company with expertise in research and development and manufacturing.
The company has two business segments: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) products and services.
The company’s product portfolio covers a wide spectrum of pharmaceutical formulations in various therapeutic areas such as cardiovascular, neuropsychiatry, anti-diabetic agents, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology in various dosage forms such as injectables, tablets, capsules, liquid orals, and ointments.
The company’s customer base comprises central and state government departments, pharmaceutical companies, public and private sector hospitals, and super stockists across India. Sai Parenteral’s started its export business in FY 2023 after acquiring two international accredited facilities in Hyderabad, Telangana, and currently serves regulated and semi-regulated markets such as Australia, New Zealand, Southeast Asia, Middle East, and Africa.
The company has five manufacturing facilities in India. Four are located in Hyderabad, Telangana. These are a GMP compliant injectable facility, a WHO-GMP injectable facility, a TGA-Australia and PIC/S accredited solid oral dosage facility, and a WHO-GMP cephalosporin facility. The company’s wholly owned subsidiary has a GMP certified facility located in Ongole, Andhra Pradesh.
As of August 31, 2025, Sai Parenteral's Ltd. had 277 full-time employees.
Sai Parenteral's - Promoter(s)
Anil Kumar Karusala
Vijitha Gorrepati
Karusala Aruna
Pre Issue Share Holding : N/A%
Post Issue Share Holding : N/A%
Sai Parenteral's IPO - Issue Objectives
Capacity expansion and upgradation of manufacturing facilities
Establishment of a new R&D Centre
Repayment / prepayment of certain outstanding borrowings
Working capital requirements
Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
General corporate purposes
Contact Details
Sai Parenteral's
Plot No 39, 5th Floor, Lavanya Arcade, Jayabheri Enclave, Gachibowli, K.V. Rangareddy, Seri Lingampally, Hyderabad, Telangana - 500032.
+91 79979 91301
Registrar Contact Details
Bigshare Services Pvt Ltd
+91-22-6263 8200
Sai Parenteral's IPO - FAQs
Ans. Sai Parenteral's Limited IPO is a Mainboard IPO. The issue is priced at ₹N/A per equity share. The minimum order quantity is N/A Shares. The IPO opens on Mar 24, 2026, and closes on Mar 27, 2026. Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Sai Parenteral's Limited IPO opens on Mar 24, 2026 and closes on Mar 27, 2026.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Sai Parenteral's Limited IPO is ₹285 Cr (Fresh Issue) + 31.57 Lakh Shares (OFS).
Ans. The Sai Parenteral's Limited IPO price band is set between ₹N/A per equity share.
Ans. To apply for Sai Parenteral's Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Sai Parenteral's Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Sai Parenteral's Limited IPO is Mar 30, 2026.
Ans. The Sai Parenteral's Limited IPO will be listed on Apr 2, 2026.
Ans. Follow the steps to check the Sai Parenteral's Limited IPO allotment status online.
